MohamedAbdalbary Egypt

Institution

Day 1 - Sunday April 14, 2024

Time Session
9 a.m.
10:30 a.m.
Gervasio Soler-Pujol Chairperson gsolerpujol@gmail.comMD
MarioSchiffer Chairperson mario.schiffer@uk-erlangen.deUniversity hospital ErlangenGermany
  • Update in Robotic Kidney Transplantation
    RajeshSivaprakasam Speaker United Kingdom
  • Progress in Xenotransplantation
    MeganSykes Speaker ms3976@cumc.columbia.eduUnited States
  • Antigen-specific Chimeric Antigen Receptor Regulatory T Cells for Use in Solid Organ Transplantation
    CarolineLamarche Speaker caroline.lamarche.1@umontreal.caUniversité de MontréalCanada
  • Post Transplant TMA-pathogenesis and Management
    LilianMonteiro P. Palma Speaker lilian.palma@icloud.comState University of CampinasBrazil
  • Q and A
Hall A
HeatherAscani Chairperson University of MichiganUnited States
KatherineTuttle Chairperson University of Washington School of Medicine, Division of NephrologyUnited States
MatthiasKretzler Chairperson University of MichiganUnited States
  • Looking for Data on Glomerular Diseases: How to Find the Treasures You Are Looking for With a Click of a Mouse
    VijiNair Speaker University of MichiganUnited States
  • Open Science in an Open Community: Resources of the Kidney Precision Medicine Project for CKD and AKI
    MatthiasKretzler Speaker University of MichiganUnited States
  • The Future is Now: How to Mine Cells and Neighborhoods of the Kidney in Health and Disease
    JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deHeidelberg UniversityGermany
  • Panel Discussion
Hall C1
EnriqueDorado Chairperson egdorado@gmail.comInstituto de Investigaciones Médicas "A. Lanari". Universidad de Buenos AiresArgentina
ShokoufehSavaj Chairperson Iran
  • Being Born Too Small: What a Nephrologist Should Know to Support Prevention of CKD in Future Generations
    DanieleTrevisanuto Speaker daniele.trevisanuto@unipd.itUniversity Hospital of Padova, ItalyItaly
  • Hypertensive Disorders of Pregnancy as a Means to Discover CKD
    Giorgina BarbaraPiccoli Speaker Centre Hospitalier Le MansFrance
  • Managing Pregnancy with Advanced CKD in a Limited-resource Setting
    AlejandraOrozco Guillen Speaker ale_gaba@hotmail.comNational Institute of Perinatology, Nephrology depMexico
  • Pre-eclampsia and its Differential Diagnosis: A Viewpoint from LMICs
    RashaShemies Speaker rashasamirtaha@gmail.comMansoura UniversityEgypt
  • Q and A
Hall D
10:30 a.m.
11 a.m.
JonathanBarratt Spotlight Speaker University of Leicester, Leicester, UKUnited Kingdom
Spotlight Stage 1 (exhibition hall)
11 a.m.
12 p.m.
AgnesFogo Chairperson United States
GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina
  • My Story
    VictoriaGray Speaker vwright_03@yahoo.comUnited States
  • CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture
    Obiageli EuniceNnodu Speaker oennodu@gmail.comUniversity of AbujaNigeria
Hall A
12:15 p.m.
1:15 p.m.
CarlaAvesani Chairperson carla.avesani@ki.seKarolinska InstituteSweden
SahirKalim Chairperson skalim@mgh.harvard.eduHarvard Medical School/ Massachusetts General Hospital United States
  • Hot Debate: Should Low Protein Diet (+/- Ketoanalogue Supplementation) Be a Part of Advanced CKD Management? - PROS
    ConnieRhee Speaker crhee@mednet.ucla.eduUCLAUnited States
  • Hot Debate: Should Low Protein Diet (+/- Ketoanalogue Supplementation) Be a Part of Advanced CKD Management? - CONS
    SwapnilHiremath Speaker University of OttawaCanada
Hall A
JavierDe Arteaga Chairperson javierdearteaga@gmail.comHospital Privado Universitario de Cordoba. Catholic University from CordobaArgentina
KarinaSoto Chairperson Centro Hospitalar de Setubal, EPE and CEDOC Universidade Nova de LisboaPortugal
SandraHerrmann Chairperson herrmann.sandra@mayo.eduMayo ClinicUnited States
  • AKI-related Cancer and Cancer Treatment-related TMA
    ClaraGarcía Carro Speaker claragarciacarro@hotmail.comSan Carlos Clinical Hospital (Madrid, Spain)Spain
  • AKI Related to Cancer Immunotherapy: Can Biomarkers Help?
    SebastianLapman Speaker lapseba@yahoo.com.arArgentina
  • Magnesium and AKI: Is There a Connection? From Bench to Bedside - What We Can Learn from Onconephrology
    JolantaMalyszko Speaker Medical University of Warsaw, PolandPoland
  • Q and A
Hall E
3 p.m.
4 p.m.
JadrankaButurović Ponikvar Chairperson University Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, SloveniaSlovenia
RodrigoCampos Chairperson rpeixotocampos@gmail.comFundação Pró-Renal, CuritibaBrazil
  • Mexico as a Training Hub for Interventional Nephrology in Latin America
    BernardoMoguel González Speaker bernardomoguel@hotmail.comInstituto Nacional de Cardiologia Ignacio Chavez Mexico cityMexico
  • Interventional Nephrology in Cameroon
    NzanaVictorine Bandolo Speaker Faculty of Medicine and Biomedical Sciences (FMBS)Cameroon
  • How to Organize an Interventional Nephrology Program Adapted to Regional Resources
    TusharVachharajani Speaker John D. Dingell Veterans Affairs Medical Center / Wayne State University School of MedicineUnited States
  • Q and A
Hall C3
FelipeInserra Chairperson felipe.inserra@gmail.comArgentina
YelenaDrexler Chairperson yrd6@miami.eduUniversity of Miami Miller School of MedicineUnited States
  • New Insights into the Mechanisms of Kidney Injury in the CRS
    WendyMccallum Speaker wmccallum@tuftsmedicalcenter.orgUnited States
  • Novel Pharmacological Treatments of the CRS
    MarkSarnak Speaker msarnak@tuftsmedicalcenter.orgTufts Medical CenterUnited States
  • Device-related Treatment for CRS
    ClaudioRonco Speaker cronco@goldnet.itInternational Renal Research Institute of VicenzaItaly
  • Q and A
Hall D
4 p.m.
4:30 p.m.
BradRovin Spotlight Speaker The Ohio State UniversityUnited States
UptalPatel Spotlight Speaker United States
Spotlight Stage 1 (exhibition hall)
4:30 p.m.
5:30 p.m.
CarlosDiaz Chairperson cdiaz@cemic.edu.arSección Nefrología, Departamento de Medicina Interna, Instituto Universitario CEMIC.Argentina
GermaineWong Chairperson University of SydneyAustralia
MarianoArriola Chairperson marianoarriola@hotmail.comSAT, SAN, Facultad de Medicina (UNL)Argentina
  • Quality and Safety in Kidney Transplantation
    WanessaClemente Speaker wanclemente@yahoo.com.brUniversidade Federal de Minas GeraisBrazil
  • Machine Perfusion of the Kidney
    HenryPleass Speaker henry.pleass@sydney.edu.auSpecialty of Surgery, Westmead Hospital, UniversitAustralia
  • Menopause and Kidney Transplantation
    SofiaAhmed Speaker sofia.ahmed@ahs.caUniversity of AlbertaCanada
  • Q and A
Hall D
ConnieRhee Chairperson crhee@mednet.ucla.eduUCLAUnited States
GerardoGamba Chairperson gamba@biomedicas.unam.mxUniversidad Nacional Autónoma de MéxicoMexico
  • Potassium-based Salt Substitutes and CVD
    HoornEwout Speaker e.j.hoorn@erasmusmc.nlErasmus Medical Center, Rotterdam, The NetherlandsNetherlands
  • Strategies for Scaling the Use of Potassium-enriched Salt
    BruceNeal Speaker lclifford@georgeinstitute.org.auThe George Institute, UNSW, Imperial CollegeAustralia
  • Use of Salt Meters to Reduce Salt Intake
    SurasakKantachuvesiri Speaker Nephrology Division, Faculty of Medicine, RamathibThailand
  • Q and A
Hall E

Day 2 - Monday April 15, 2024

Time Session
9 a.m.
10:30 a.m.
AdelaMattiazzi Chairperson amattiazzi@med.miami.eduTTS, SAT, ASN, AST, United StatesUnited States
RubenSchiavelli Chairperson rubenschiavelli@yahoo.com.arArgentina
  • Organ Trafficking: A Complex and Devastating Reality
    DominiqueMartin Speaker Deakin UniversityAustralia
  • The Many Challenges of Kidney Transplantation in Developing Countries: Latin America
    LuisMorales Buenrostro Speaker luis_buenrostro@yahoo.comINSTITUTO NACIONAL DE CIENCIAS MEDICAS Y NUTRICION SALVADOR ZUBIRANMexico
  • Acute Allograft Dysfunction
    Zubeyde SerhanTuglular Speaker stuglular@marmara.edu.trMarmara University School of Medicine, Division of NephrologyTürkiye
  • Transplant Implications for APOL1 Testing in South American Populations
    FernandaSales Luiz Vianna Speaker fslvianna@gmail.comUniversidade Federal do Rio Grande do SulBrazil
  • Q and A
Hall A
GermaineWong Chairperson University of SydneyAustralia
PierreRonco Chairperson Hôpital TenonFrance
  • KI Highlights
    PierreRonco Speaker Hôpital TenonFrance
  • KI Highlights 1
    Eugene Yu HinChan Speaker The Chinese University of Hong Kong, Hong Kong Children's HospitalHong Kong, China
  • KI Highlights 2
    MuzamilHassan Speaker Department of Medicine, Obafemi Awolowo University, Ile-Ife, NigeriaNigeria
  • KI Highlights 3
    VeronicaMiguel Speaker Spanish National Centre for Cardiovascular ResearchSpain
  • KI Highlights 4
    GriffithPerkins Speaker Australia
  • KIR - Update
    JaiRadhakrishnan Speaker Columbia University in the City of New YorkUnited States
  • KIR Highlights 1
    SumitMohan Speaker Columbia UniversityUnited States
  • KIR Highlights 2
    AndreaViecelli Speaker University of QueenslandAustralia
  • Presentation of Best Reviewer Awards
    BradRovin Speaker The Ohio State UniversityUnited States
  • Presentation of Basic Science Awards (Early Career Researchers Awards)
    ChristophKuppe Speaker Department of Nephrology, RWTH University Aachen, GermanyGermany
  • Presentation of Clinical Science Awards (Early Career Researchers Awards)
    IsabelleAyoub Speaker The Ohio State UniversityUnited States
  • Q and A
    BradRovin Speaker The Ohio State UniversityUnited States
Hall C2
TaraChang Chairperson tichang@stanford.eduStanford UniversityUnited States
Veronica Ferraris Chairperson veronica.ferraris@hospitalitaliano.org.arServicio de Nefrología Pediátrica. Hospital Italiano de Buenos Aires. (Argentina)
  • Behind the Numbers: Exploring the Molecular Mechanisms of Hypertension
    GerardoGamba Speaker gamba@biomedicas.unam.mxUniversidad Nacional Autónoma de MéxicoMexico
  • Hypertension - the Cutting Edge: Is It Time for Sex-specific Management of Hypertension?
    TaliElfassy Speaker t.elfassy@med.miami.eduUnited States
  • State-of-the-Art Treatment of Hypertension in Pediatrics With CKD
    RahulChanchlani Speaker chanchlr@mcmaster.caMcMaster Children's Hospital, Hamilton, CanadaCanada
  • State-of-the-Art Treatment of Hypertension in Adults With CKD
    SusanneNicholas Speaker sunicholas@mednet.ucla.eduDavid Geffen School of Medicine at UCLAUnited States
  • Q and A
Hall D
12:15 p.m.
1:15 p.m.
Carlos LuisBlanco Chairperson clbblanco@yahoo.com.arCARLOS LUIS BLANCO, ISN EMERIT MEMBER, ARGENTINA Argentina
MarcelloTonelli Chairperson University of CalgaryCanada
TalerngsakKanjanabuch Chairperson Faculty of Medicine, Chulalongkorn UniversityThailand
  • KDIGO 2024 Anemia CKD Guideline: Overview on Methodology and Key Guidance
    EviNagler Speaker Nephrology Department, Ghent University Hospital, Belgium
  • Practical Guideline Applications for Patients with Anemia CKD Not on Dialysis
    JoséA. Moura-Neto Speaker jamouraneto@hotmail.comBrazilian Society of NephrologyBrazil
  • Practical Guideline Applications for Select Patients With Anemia: Dialysis, Kidney Transplant Recipients, and Children with CKD
    MarcelloTonelli Speaker University of CalgaryCanada
  • Q and A
Hall E
1 p.m.
1:45 p.m.
DiegoRigo Spotlight Speaker diegohrigo@gmail.comArgentina
Jaime ManuelRestrepo Restrepo Spotlight Speaker restrepojaime@hotmail.comColombia
Pablo MartinJimenez Spotlight Speaker pmjimenezlorenzo@yahoo.com.arArgentina
Tasnuva SarahKashem Spotlight Speaker Bangladesh
RukshanaShroff Spotlight Chairperson MD, FRCPCH, PhDUnited Kingdom
Spotlight Stage 2
2:45 p.m.
3:15 p.m.
Laura Lunardi Speaker laura.lunardi@sa.gov.auAustralia
Ana Elizabeth pradofigueiredo Spotlight Speaker Pontifícia Universidade Católica do Rio Grande do Brazil
HelenHurst Spotlight Speaker h.e.hurst@salford.ac.ukUniversity of Salford and Northern Care Alliance NUnited Kingdom
RachaelWalker Spotlight Chairperson University of Auckland, New ZealandNew Zealand
Spotlight Stage 1 (exhibition hall)
3 p.m.
4 p.m.
AlessiaFornoni Chairperson University of Miami United States
MichelleRheault Chairperson rheau002@umn.eduUniversity of MinnesotaUnited States
  • Predicting the Risks of Kidney Failure and Death in Adults With Moderate-to-severe Chronic Kidney Disease (KDpredict)
    PietroRavani Free Communication pravani@ucalgary.caUniversity of CalgaryCanada
  • Plasma Exchange in ANCA Associated Vasculitis GN: Update After Pexivas
    Wladimir MietekSzpirt Speaker wladimir.mietek.szpirt.01@regionh.dkRigshospitalet, University of Copenhagen, Dept. of Nephrology, Denmark, Senior Research ConsultantDenmark
  • EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY: INTERIM RESULTS FROM THE PHASE 3 APPLAUSE-IgAN STUDY
    DanaRizk Free Communication drizk@uabmc.eduUniversity of Alabama at BirminghamUnited States
  • SPARSENTAN VS IRBESARTAN IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN): SUBGROUP ANALYSES OF 2-YEAR RESULTS FROM THE PIVOTAL PHASE 3 PROTECT TRIAL
    JonathanBarratt Free Communication University of Leicester, Leicester, UKUnited Kingdom
  • PREGNANCY AMONG WOMEN ON CHRONIC DIALYSIS : THE FRENCH COHORT
    CécileCouchoud Free Communication cecile.couchoud@biomedecine.frREIN registry, Agence de la biomédecine, FranceFrance
Hall A
MitchellRosner Chairperson Univeristy of Virginia HealthUnited States
  • Overview of Hyponatremia
    Angela Yee-MoonWang Speaker Hong Kong/SingaporeSingapore
  • Pro: Current Guidelines are Appropriate
    HelbertRondon-Berrios Speaker rondonberriosh@upmc.eduUniversity of Pittsburgh School of MedicineUnited States
  • Con: Current Guidelines are Too Conservative
    CarlosAyus Speaker carlosayus@yahoo.comUniversity of California IrvineUnited States
  • Discussion
Hall C3
4:30 p.m.
5:30 p.m.
CarolineLamarche Chairperson caroline.lamarche.1@umontreal.caUniversité de MontréalCanada
Gustavo CristianGreloni Chairperson gustavo.greloni@hospitalitaliano.org.arArgentina
  • MGRS: Should All Forms Need Clonal Therapy?
    FrankBridoux Speaker f.bridoux@chu-poitiers.frDepartment of Nephrology and French Reference Center for AL amyloidosis and MGRS, University Hospital, Poitiers, FranceFrance
  • Renal Amyloidosis: What Is New?
    Veronica Torres CostaSilva Speaker veronica.torres@hc.fm.usp.brSão Paulo State Cancer Institute - University of São PauloBrazil
  • Can We Perform a Transplant in Patients with Myeloma and Amyloidosis?
    SabineKaram Speaker University of MinnesotaUnited States
  • Q and A
Hall A

Day 3 - Tuesday April 16, 2024

Time Session
9 a.m.
10:30 a.m.
CarlosSchreck Chairperson carlos.schreck@gmail.comHospital Italiano de Buenos Aires- NephrologyArgentina
KellyHaughton Chairperson kidneydoctorpanama@gmail.comSLANH, PanamaPanama
  • Why Are Fewer Than I% Of Hypertensive Patients Ever Screened For Primary Aldosteronism?
    John Funder Speaker John.Funder@hudson.org.auThe Hudson Institute of Medical Research Clayton 3168 Victoria Australia; Monash University, Clayton 3600 Victoria AustraliaAustralia
  • Aldosterone and Disease
    JordanaCohen Speaker jco@pennmedicine.upenn.eduUniversity of PennsylvaniaUnited States
  • New Trials Using Aldosterone Synthese Blockade
    MichelAzizi Speaker michel.azizi@aphp.frUniversité Paris Cité, Hypertension department, HôFrance
  • Targeting MR for Heart and Kidney Protection
    HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands
  • Q and A
Hall E
9 a.m.
10:30 a.m.
Juan ManuelMejia Vilet Chairperson jmmejia@hotmail.comInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránMexico
ValeriaAlberton Chairperson vgalberton@gmail.comHospital Fernandez/ Hospital El CruceArgentina
  • Updates on IgAN Management
    HernánTrimarchi Speaker HOSPITAL BRITÁNICO DE BUENOS AIRESArgentina
  • Membranous GN Classification and Management
    PierreRonco Speaker Hôpital TenonFrance
  • MPGN Updates
    SanjeevSethi Speaker Mayo ClinicUnited States
  • Managing Vasculitis
    RobertaFenoglio Speaker roberta.fenoglio@unito.itOspedale San Giovanni BoscoItaly
  • Q and A
Hall A
11 a.m.
12:15 p.m.
AlessiaFornoni Chairperson University of Miami United States
LizLightstone Chairperson Imperial College LondonUnited Kingdom
MasaomiNangaku Chairperson Japan
  • Acceptance Speech: Bywaters Award
    MotokoYanagita Speaker Kyoto UniversityJapan
  • Insights into SGLT2 Inhibitors: A Story of Discovery. Donald Seldin Lecture
    EleFerrannini Speaker eleferrannini@gmail.comUniversity of PisaItaly
  • ELP2 Graduation
    MasaomiNangaku Speaker Japan
Hall A
12:30 p.m.
1:30 p.m.
MarceloOrías Chairperson marcelo.orias@gmail.comArgentina
MarkSarnak Chairperson msarnak@tuftsmedicalcenter.orgTufts Medical CenterUnited States
  • Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - PROS
    TaraChang Speaker tichang@stanford.eduStanford UniversityUnited States
  • Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - CONS
    JordanaCohen Speaker jco@pennmedicine.upenn.eduUniversity of PennsylvaniaUnited States
Hall A

Pre-Congress - Saturday April 13, 2024

Time Session
9 a.m.
11 a.m.
AhmedSokwala Chairperson drsokwala@gmail.comAga Khan University Hospital NairobiKenya
ArifAsif Chairperson arif.asif@hmhn.orgUnited States
GriseldaBratti Chairperson griselda.bratti@hospitalitaliano.org.arHospital Italiano of Buenos Aires. Argentina Argentina
JadrankaButurović Ponikvar Chairperson University Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, SloveniaSlovenia
  • Tunneled Hemodialysis Catheters
    OctavioSalgado Speaker ojsalg@hotmail.comChair of Nephrology, School of Medicine, Universidad Católica de Cuenca, Ecuador.Ecuador
  • Insertion of PD Catheters
    BrettCullis Speaker University of Cape TownSouth Africa
  • Biopsy of Native and Transplanted Kidney
    FedericoLevy Speaker levyfede@gmail.comDrArgentina
  • Hands-on Modules - HD
  • Hands-on Modules - PD
  • Hands-on Modules - Kidney Biopsy
Hall D
11:30 a.m.
1:30 p.m.
AhmedSokwala Chairperson drsokwala@gmail.comAga Khan University Hospital NairobiKenya
ArifAsif Chairperson arif.asif@hmhn.orgUnited States
GriseldaBratti Chairperson griselda.bratti@hospitalitaliano.org.arHospital Italiano of Buenos Aires. Argentina Argentina
JadrankaButurović Ponikvar Chairperson University Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, SloveniaSlovenia
  • Physical Evaluation of Arteriovenous Fistula
    JakobGubenšek Speaker jakob.gubensek@kclj.siUniversity Medical Center Ljubljana, SloveniaSlovenia
  • Vascular Access Related Endovascular Procedures
    AnilAGARWAL Speaker University of California San Francisco, Fresno, USUnited States
  • Approach to Thrombosed Vascular Access
    ArifAsif Speaker arif.asif@hmhn.orgUnited States
  • Hands-on Modules - Arteriovenous Fistula
  • Hands-on Modules - Vascular Access Related Endovascular Procedures
  • Hands-on Modules - Thrombosed Vascular Access
Hall D
2:15 p.m.
4:15 p.m.
AhmedSokwala Chairperson drsokwala@gmail.comAga Khan University Hospital NairobiKenya
ArifAsif Chairperson arif.asif@hmhn.orgUnited States
GriseldaBratti Chairperson griselda.bratti@hospitalitaliano.org.arHospital Italiano of Buenos Aires. Argentina Argentina
JadrankaButurović Ponikvar Chairperson University Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, SloveniaSlovenia
  • Doppler Ultrasonography of Native and Transplanted Kidney
    JadrankaButurović Ponikvar Speaker University Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, SloveniaSlovenia
  • Ultrasonography Volume Status Assessment (Lungs, IVC) and Limited Cardiac Echo
    SuryatiYakob Speaker suryatiyakob@gmail.comHospital Kuala LumpurMalaysia
  • Ultrasonography Evaluation of Arteriovenous Fistula
    AhmedSokwala Speaker drsokwala@gmail.comAga Khan University Hospital NairobiKenya
  • Hands-on Modules - Ultrasonography Volume Status Assessment (Lungs, IVC) and Limited Cardiac Echo
  • Hands-on Modules - Doppler Ultrasonography of Native and Transplanted Kidney
  • Hands-on Modules - Ultrasonography Evaluation of Arteriovenous Fistula
Hall D
4:30 p.m.
6 p.m.
  • ISN President's Address
    MasaomiNangaku Speaker Japan
  • Tribute to Stewart Cameron
  • Welcome by WHO Director of Non-Communicable Diseases Dr Bente Mikkelsen
  • Welcome by Dr. Marina Papaginovic, SAN President; Dr. Guillermo Rosa Diez, WCN Local Organising Group Chair; and Dr. Jorge Rico, SLANH President and WCN Local Organizing Group co-Chair
    GuillermoRosa Diez Speaker guillermo.rosadiez@hospitalitaliano.org.arHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina
    JorgeRico Speaker jorgericof@yahoo.comColombia
    MariaPapaginovic Leiva Speaker drapapaginovicleiva@gmail.comArgentina
  • Welcome by Minister of Health for Buenos Aries Dr Fern
  • Welcome by SPWG Chair Alessia Fornoni
    AlessiaFornoni Speaker University of Miami United States
  • The Origin of the Universe
    DanielDe Florian Speaker deflo@unsam.edu.arUniversidad Nacional de San MartinArgentina
  • Acceptance Speech: Hamburger Award
    AdeeraLevin Speaker University of British Columbia and Providence Health CareCanada
Hall A
6:45 p.m.
7:15 p.m.
EtienneNtabanganyimana Spotlight Speaker Rwanda
MariaPippias Spotlight Speaker University of BristolUnited Kingdom
FergusCaskey Spotlight Chairperson University of Bristol, UKUnited Kingdom
MariaGonzalez Spotlight Chairperson registro@slanh.netSLANHUruguay
Spotlight Stage 1 (exhibition hall)